STOCK TITAN

Restart Life Advances BrainBalls Toward Planned 2027 Canadian Launch and U.S. Expansion

(Very High)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Restart Life Sciences (NMLSF) has advanced BrainBalls snack bites into final commercialization stages ahead of a planned Canadian launch in 2027. Developed with Brain Balls under a December 2024 joint venture, the product was introduced in June 2025.

The company plans to sell through Canadian e-commerce platforms and use Holy Crap Foods' existing warehousing and logistics facility in Gibsons, British Columbia. U.S. expansion is a 2027 priority, with online marketplaces and distribution options to be evaluated. Management intends to use early Canadian sales, repeat purchases and fulfillment costs to guide the timing and scope of the U.S. rollout.

Loading...
Loading translation...

Positive

  • Minor point. Forward-looking: it has not happened yet and may not happen.BrainBalls has entered final commercialization stages, with a Canadian e-commerce launch planned for 2027.
  • Minor point. Forward-looking: it has not happened yet and may not happen.U.S. expansion is a company priority for 2027, with marketplaces and distribution options to be evaluated.
  • Minor point. Forward-looking: it has not happened yet and may not happen.Existing Holy Crap Foods infrastructure is planned to support BrainBalls inventory, fulfillment and distribution.

Negative

  • Minor point. Forward-looking: it has not happened yet and may not happen.U.S. rollout timing and scope depend on early Canadian sales, repeat purchases and fulfillment costs.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

Vancouver, British Columbia--(Newsfile Corp. - November 17, 2026) - Restart Life Sciences Corp. (CSE: HEAL) (FSE: HN30) (OTC Pink: NMLSF) ("Restart Life" or the "Company") is pleased to announce that BrainBalls™, a line of snack bites developed in collaboration with Brain Balls Inc., has entered the final stages of commercialization. The Company plans to launch BrainBalls™ first in Canada in 2027 and has identified expansion into the United States as a priority for the same year.

BrainBalls™ was introduced in June 2025 under Restart Life's December 2024 joint venture with Brain Balls Inc. Following the launch of Holy Crap Protein+, the Restart Life and Holy Crap Foods teams are applying their product development and distribution expertise to prepare BrainBalls™ for its planned 2027 launch.

Cannot view this image? Visit: https://images.newsfilecorp.com/files/8801/324407_1re.jpg

To view an enhanced version of this graphic, please visit:
https://images.newsfilecorp.com/files/8801/324407_314148ad04fca8f1_001full.jpg

Restart Life intends to introduce BrainBalls™ to Canadian customers through various e-commerce platforms. The Company also plans to use the existing warehousing and logistics capabilities at Holy Crap Foods' facility in Gibsons, British Columbia, to support inventory management, order fulfillment and distribution. The Company referenced the facility and its operating infrastructure in its November 11, 2026 announcement of consumer packaged goods co-packing services.

Restart Life plans to evaluate online marketplaces and distribution options in the United States. Management intends to use early Canadian sales, repeat purchases and fulfillment costs to guide the timing and scope of the U.S. rollout.

"With Holy Crap Protein+, our Restart Life and Holy Crap Foods teams took two products from concept through to commercial launch. We're applying that experience to BrainBalls™," said Steve Loutskou, Chief Executive Officer of Restart Life. "Canada is our planned first market, and expanding into the United States is a priority for 2027. What we learn from the Canadian launch will help us decide which U.S. channels to pursue and how much resources to commit."

Restart Life Sciences thanks its shareholders for their ongoing support as the Company continues to execute its commercialization strategy.

About Restart Life Sciences Corp.
Restart Life Sciences Corp. is a Canadian-based life sciences company listed on the CSE. For more information about Restart Life, please visit the Company's website at www.restartlife.co.

About Holy Crap Foods Inc.
Holy Crap Superseed Cereal and Holy Crap Superseed Oatmeal are premium functional food brands offering nutrient-dense, clean-label products made with simple, high-quality ingredients. Based in Gibsons, British Columbia, the brand has built a loyal and growing customer base across Canada, driven by strong consumer trust and repeat purchases.

Positioned within the fast-growing gut health and wellness category, Holy Crap's gluten-free, non-GMO, high-fiber products support digestive health and sustained energy, while gaining traction as a trusted, everyday solution for health-conscious consumers. For more information, visit www.holycrap.com

Forward-Looking Statements
This news release contains statements that constitute "forward-looking statements." Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause Restart Life Sciences' actual results, performance or achievements, or developments in the industry to differ materially from the anticipated results, performance or achievements expressed or implied by such forward-looking statements. Forward-looking statements are statements that are not historical facts and are generally, but not always, identified by the words "expects," "plans," "anticipates," "believes," "intends," "estimates," "projects," "potential" and similar expressions, or that events or conditions "will," "would," "may," "could" or "should" occur.

Neither the Canadian Securities Exchange nor its Market Regulator (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.

On behalf of the Board of Directors
Steve Loutskou
Chief Executive Officer, Restart Life Sciences Corp.
Tel: +1 (778) 819-0244
Email: hello@restartlife.co

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/324407

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When does Restart Life Sciences plan to launch BrainBalls in Canada and the United States?

Restart Life plans to launch BrainBalls in Canada in 2027 and has identified U.S. expansion as a priority for the same year. Management intends to use early Canadian sales, repeat purchases and fulfillment costs to guide the timing and scope of the U.S. rollout.

Keep reading